Apollon Wealth Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Apollon Wealth Management's DXCM Position: Q3 2026 in Review
Apollon Wealth Management reduced its DexCom (DXCM) stake by 30% in Q3 2026, selling an estimated $3.29M and leaving 94,315 shares worth $8.14M. The position accounts for 0.09% of the portfolio, ranked #186.
Apollon Wealth Management first reported a position in DXCM in Q2 2020 and has held it in 21 quarters since. The position peaked at $9.02M in Q2 2026. 620 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.
- Apollon Wealth Management held 94,315 shares of DexCom worth $8.14M as of Q3 2026.
- Apollon Wealth Management sold 39,574 DexCom shares in Q3 2026, an estimated $3.29M.
- DexCom made up 0.09% of Apollon Wealth Management's portfolio in Q3 2026, its #186 holding.
- Apollon Wealth Management first reported a position in DexCom in Q2 2020 and has held it in 21 quarters since.
- Apollon Wealth Management's DexCom position peaked at $9.02M in Q2 2026.
- 620 funds tracked by Wall St. Rank held DexCom as of Q3 2026.
Based on Apollon Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.